COVID-19: Variant has strong cell binding: ‘Fugaku’ analyzes
Kyoto University: Platelets are made from iPS cells and administered: Venture ‘Megakaryon’
Kyoto University: Granted iPS cell license to Avery: Cardiomyocyte manufacturing method
COVID-19: Osaka University artificially synthesizes mutant virus: shortened to 2 weeks